Tissue Phenomics Blog

5B_Her2-classified.jpg

Posts by Topic

see all

Topics:  image analysis, clinical trials, drug development, Immunotherapy, immuno-oncology, predictive biomarkers, cancer treatment

How Image Analysis Can Improve the Results of Drug Development and Clinical Trials

Dec 12, 2016 4:00:00 AM

In recent years there have been several potentially life-saving medications approved for cancer treatment, including targeted molecular entities and biologics such as Opdivo (nivolumab) and Keytruda (pembrolizumab). Oncology drugs remain a pharmaceutical priority and investments into cancer account for 30% of all pre-clinical and phase 1 clinical development expenditures. There is an impressive list of close to 800 drugs and vaccines currently in the industry-wide development pipeline, many with promising results in early-stage clinical trials. However by historical measures only 10% or fewer of these drugs will ever make it through FDA approval and become part of routine patient care.

Read More